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Objectives: Cleaning workers have an increased risk of asthma but the underlying mechanisms
are largely unknown. We studied functional and biological characteristics in asthmatic cleaners
and compared these to healthy cleaners.
Methods: Forty-two cleaners with a history of asthma and/or recent respiratory symptoms and
53 symptom-free controls were identified. Fractional exhaled nitric oxide (FeNO) was mea-
sured and forced spirometry with reversibility testing was performed. Total IgE, pulmonary sur-
factant protein D and the 16 kDa Clara Cell secretory protein were measured in blood serum.
Interleukins and other cytokines, growth factors, cys-leukotrienes and 8-isoprostane were
measured in exhaled breath condensate. Information on occupational and domestic use of
cleaning products was obtained in an interview. Associations between asthma status, specificof Montreal Hospital Research Centre (CRCHUM), 3875 Rue Saint-Urbain, Montreal, QC H2W 1V1,
; fax: þ1 514 412 7106.
il.com (D. Vizcaya).
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674 D. Vizcaya et al.characteristics and the use of cleaning products were evaluated using multivariable linear and
logistic regression analyses.
Results: Asthma was associated with an 8% (95% confidence interval (CI) 1e15%) lower post-
bronchodilator FEV1, a higher prevalence of atopy (42% vs. 10%) and a 2.9 (CI 1.5e5.6) times
higher level of total IgE. Asthma status was not associated with the other respiratory bio-
markers. Most irritant products and sprays were more often used by asthmatic cleaners. The
use of multiuse products, glass cleaners and polishes at work was associated with higher FeNO,
particularly in controls.
Conclusions: Asthma in cleaning workers is characterised by non-reversible lung function de-
crement and increased total IgE. Oxidative stress, altered lung permeability and eosinophilic
inflammation are unlikely to play an important underlying role, although the latter may be af-
fected by certain irritant cleaning exposures.
ª 2013 Elsevier Ltd. All rights reserved.Introduction
A growing body of epidemiologic research now suggests that
cleaning workers are at increased risk of asthma and related
respiratory symptoms.1e5 In Catalonia, Spain, cleaning-
related exposures have been identified as one of the main
causes of physician-diagnosed occupational asthma.6 Among
the cleaning-related exposures investigated, occupational
use of products containing respiratory irritants such as hy-
pochlorite bleach and ammonia have been associated with
asthma and asthma-related conditions.7e10 Domestic use of
cleaning products, in particular those in spray form, has
been also suggested as a risk factor for asthma.11,12
Despite the increasing epidemiological evidence sup-
porting elevated risks of asthma among cleaners,1,5 limited
data are available to describe the physiologic characteristics
of cleaning-related asthma or suggest underlying mecha-
nisms by which cleaning-related exposures may impact res-
piratory health. It has been proposed that inhalation of
compounds with respiratory irritant properties may induce
bronchial epithelial damage and facilitate allergic sensiti-
zation by triggering a pro-inflammatory response, neuro-
genic inflammation, increased lung permeability, and
remodelling of the airways epithelium.13 Non-allergic-
mediated bronchial inflammation has also been described;
specifically, occupational and non-occupational exposures
alike may lead to non-eosinophilic bronchial inflammation
and the onset or aggravation of asthma through non-allergic
pathways.14 Specific sensitization to the individual compo-
nents of cleaning product formulations may also play a role
in the observed risk of asthma among cleaners.15
Such inflammatory processes may be detected by char-
acterization of biomarkers of respiratory health. Cytokines
and growth factors involved in the inflammatory response in
asthma can be measured in exhaled breath condensate
(EBC), a suitable non-invasive matrix for this purpose.16
Eosinophilic inflammation can be evaluated using the
fraction of exhaled nitric oxide (FeNO).17 Finally, bronchial
epithelium damage may alter lung permeability, and can be
assessed by the blood serum levels of pulmonary proteins
which move passively across the alveolar epithelial barrier
into the peripheral blood stream when the lung epithelium
permeability is compromised.18
We conducted this study to describe the functional and
biological characteristics of asthma in cleaning workers andto compare a group of cleaners with asthma with a group of
cleaning workers free of respiratory symptoms. These
findings are based on analysis of the second stage of
a multi-stage study of cleaning-related exposures and
asthma. In the first stage of the project, we evaluated risk
factors for asthma and asthma-related symptoms among
professional cleaning workers.9 In this second stage, we
assess the inflammatory profile, oxidative stress, sensiti-
sation to aeroallergens, lung epithelium permeability,
bronchial hyperresponsiveness and lung function in asth-
matic and non-asthmatic cleaners identified in the first
stage of the project. With this analysis, we provide
a description of the physiological and functional charac-
teristics of asthma in cleaning workers compared to
a healthy population with similar sociodemographic char-
acteristics and evaluate associations of domestic and
occupational use of cleaning products with asthma and
biomarkers of respiratory health.
Methods
Study design and population
We conducted a case-control study nested within a large
cross-sectional study of asthma among cleaning company
employees in Barcelona, Spain. The study design and
methods of the questionnaire survey have been described
previously.9 Briefly, in 2008 we obtained self-administered
questionnaires including information on respiratory symp-
toms and asthma from 761 cleaning workers currently
employed at 37 cleaning companies in Barcelona. No mea-
surements of lung function or any biomarker were con-
ducted for the first stage of the project. Based on such
questionnaires, we identified 70 prevalent cases with
asthma symptoms (wheeze, chest tightness, breathlessness
at rest, breathlessness after exercise and nocturnal
breathlessness attack) in the last year and/or with a history
of asthma and 121 controls without any lower tract respi-
ratory symptom and without a history of asthma. A similar
symptom-based definition of asthma has been used previ-
ously.7 Between December 2008 and September 2009,
selected cases and controls were interviewed by tele-
phone. Those who were still employed as cleaning workers
and who still met the case and control inclusion criteria
were invited to participate in a detailed clinic visit. Forty-
Figure 1 Selection flowchart of the study population from a previous cross-sectional study in cleaning workers.
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676 D. Vizcaya et al.two cases (60%) and fifty-three controls (44%) were finally
enrolled in the study (Fig. 1). Eligible participants and non-
participants did not differ in age, educational level, sex,
smoking status and symptoms either among cases or con-
trols. A higher prevalence of adult-onset asthma was found
among non-participant cases compared to participants
(Supplement Table 1).
The present study was approved by the ethics commit-
tee of Parc de Salut Mar, Barcelona, and the participants
provided written informed consent.
Face-to-face interview
Information on respiratory symptoms, job history, domestic
and occupational cleaning-related exposures, smoking
habits and demographic characteristics was obtained during
a computer-assisted face-to-face interview. Respiratory
health questions were taken from the Spanish version of the
European Community Respiratory Health Survey ques-
tionnaire.19 Data on the use of cleaning products in the
previous year and the average number of hours per week of
product use was obtained separately for domestic and
occupational cleaning activities. The selected list of clean-
ing products was based on findings from previous studies.7,9
Lung function testing
Forced expiratory volume in the first second (FEV1), forced
vital capacity (FVC) and forced expiratory flow between
25% and 75% of FVC (FEF25e75%) were measured with an
EasyOne portable spirometer (ndd Medical Technologies,
Zu¨rich, Switzerland) before and 15 min after the admin-
istration of 400 mg salbutamol via metered dose inhaler,
following standard recommendations.20,21 FEV1 and FVC
were expressed as percentages of the age-, sex- and height-
specific predicted values. All models were adjusted for
cigarette pack-years.
All participants who were eligible for methacholine
challenge testing were invited to a second clinic visit where
a bronchial hyperresponsiveness (BHR) test was conducted
following the ECRHS protocol.19
Fraction of exhaled nitric oxide (FeNO)
FeNO was measured using an electrochemical portable
device (NIOX-MINO; Aerocrine, Solna, Sweden) with a con-
stant airflow rate of 50 mL/s and following international
recommendations.22 Levels were expressed as parts per
billion (ppb).
Determination of biological markers in exhaled
breath condensate (EBC)
EBC was collected using an EcoScreen condenser (Jaeger
GmbH, Wu¨rzburg, Germany) following ATS/ERS Task Force
recommendations.23 Treatment of samples has been
described previously.24,25 8-Isoprostane was analysed using
an enzyme-linked immunosorbent assay (ELISA; Cayman
Chemical, Ann Arbor, MI, USA). BD Cytometric Bead Array
(CBA; BD Biosciences, Erembodegem, Belgium) and the BD
FACSCalibur Flow Cytometer (Becton Dickinson, San Jose,CA, USA), a particle-based immunoassay, were used to
measure the following 10 cytokines and 2 growth factors:
vascular endothelial growth factor (VEGF), basic fibroblast
growth factor (FGF), tumour necrosis factor (TNF), inter-
leukin (IL) 2, IL-4, IL-5, IL-8, IL-10, IL-12, IL-13, interferon-
gamma (IFN-g), and IFN-geinduced protein 10 (Ip10). We
used the manufacturer recommendations of the corre-
sponding lower limit of detection for each biomarker.
Determination of biological markers in blood serum
Blood serum samples were collected by venipuncture. CC16
and SP-D were analysed using commercial kits (Biovendor
Laboratornı´ medicı´na a.s., Modrice, Czech Republic).24 The
concentration of total IgE, and specific IgE against Dust
mite (Dermatophagoides pteronyssinus) and latex in serum
was determined using Chemoluminescent immunoanalysis
(IMMULITE 2000. Siemens). We evaluated the levels of
specific IgE against common aeroallergens using the Pha-
diatop test (Pharmacia ImmunoCAP; Pharmacia, Uppsala,
Sweden) as a proxy for atopy.
Data analysis
Levels of all cytokines and growth factors measured in EBC
were dichotomised as detectable or non-detectable to
increase the statistical power. Analysis was conducted if
more than 5% of cases and controls were detectable. The
distributions of the concentration of all biomarkers followed
a log-normal shape. The associations between asthma and
dichotomous outcomes were evaluated using multivariable
logistic regression, while associations with (log-trans-
formed) continuous outcomes were evaluated using multi-
variable linear regression. Associations with biomarkers
were expressed as Geometric Mean Ratios, computed as the
exponential of the beta coefficient obtained from multi-
variable linear regression models. All models were adjusted
for age, sex and smoking status (never, former and current
smoker). The association between asthma and the use of
cleaning products was evaluated with multivariable logistic
regression models for each cleaning product analysed. All
models were adjusted by domestic use of the studied
cleaning product, occupational use of the studied cleaning
product, age, sex and smoking status (never, former and
current smoker). Statistical analyses were performed using
SAS version 9.1 (SAS Institute Inc., Cary, NC, USA).
Results
Cases and controls were both predominantly women
(Table 1). Cases were on average six years younger than
controls and more likely to smoke. A relatively high pro-
portion of both groups was born outside Spain (30%) and
reported educational attainment of primary education or
less (cases: 62%, controls: 70%). Most cases and controls
were overweighted (60% and 64% with BMI  25, respec-
tively). The score of asthma26 among cases was on average
2.2, 24% of them reported having had asthma confirmed by
a physician, and 17% had their first asthma attack after the
age of 16. Nineteen cases (45%) presented current asthma
as defined in previous studies.9 Atopy and sensitisation to
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controls (Table 1).
Lung function testing
Forced spirometry tests of 28 (67%) cases and 44 (83%)
controls met the ATS/ERS quality criteria (Table 2) and
were, therefore, considered for analyses. Measurements of
FEV1, the FEV1/FVC ratio and FEF25%e75% were significantly
lower in cases than in controls. No significant differences in
FVC were observed. A higher proportion of cases as com-
pared to controls presented a percentage of predicted FEV1
below 85% both before and after the inhalation of bron-
chodilator. On the other hand, we found no differences inTable 1 Demographic and respiratory health character-
istics of the studied population.
Controls
n Z 53
Cases
n Z 42
Female 47 (89%) 39 (93%)
Age, mean  SD 48  8 42  10
Smoking
Never smoker 30 (57%) 14 (33%)
Former smoker 15 (28%) 7 (17%)
Packs-year, mean  SD 5  6 28  31
Current smoker 8 (15%) 21 (50%)
Packs-year, mean  SD 15  8 29  24
Country of birth
Spain 37 (70%) 30 (71%)
Other 16 (30%) 12 (29%)
Educational level
Less than primary school 7 (13%) 5 (12%)
Primary school 30 (57%) 21 (50%)
Secondary school or higher 16 (30%) 16 (38%)
Body mass index (kg/m2)
<20 2 (4%) 1 (2%)
20 to 24.9 17 (32%) 16 (38%)
25 to 29.9 25 (47%) 12 (29%)
 30 9 (17%) 13 (31%)
Years employed as a cleaning
worker, mean  SD
11.6  8.0 12.0  8.2
Doctor diagnosed asthma e 10 (24%)
Adult onset asthma e 7 (17%)
Current asthma a e 19 (45%)
Asthma score, mean (SD) e 2,2 (1,4)
Chronic cough e 16 (38%)
Chronic phlegm e 10 (24%)
Upper respiratory tract
symptoms
19 (36%) 27 (64%)
Atopyb 5 (10%) 17 (42%)
Sensitisation to latexc 1 (2%) 3 (7%)
Sensitisation to
D. pteronyssinus c
2 (4%) 13 (31%)
n (%) unless otherwise indicated.
a Wheeze with breathlessness and/or attack of asthma in the
last year and/or currently taking medication for asthma.
b Phadiatop test positive. [specific IgE]>0.35 kU/L at least for
1 of 10 common aeroallergens.
c Concentration of specific IgE in blood serum higher than
0.35 kU/L.the proportion of cases and controls that showed a per-
centage of predicted FVC below 85%. Reversibility of
bronchial obstruction was similar in cases and controls both
as a percentage of change and as a difference of FEV1 or
FVC before and after the inhalation of bronchodilator. A
subgroup of 11 cases underwent methacholine challenge
testing and showed higher prevalence of BHR compared to
11 controls.
Biological markers
Levels of FeNO, SP-D and CC16 were similar in both groups
(Table 3). Cases and controls did not differ in the per-
centage of detectable levels of ILs and growth factors. Cys-
leukotrienes and 8-isoprostane were detectable in almost
all the analysed samples of EBC and no differences between
cases and controls were found in the average level of both
markers. Cases had significantly higher levels of total serum
IgE than controls after adjusting by sex, age and smoking
status.
Domestic and occupational use of cleaning products
and asthma
Cases and controls reported frequent domestic and occu-
pational use of hypochlorite bleach, soaps or detergents
and degreaser (Table 4). The association with asthma
symptoms varied depending on the cleaning product and
whether the exposure occurred at home or at work. Cases
reported a more frequent use of multi-use products com-
pared to controls. The highest risk of asthma was observed
among those who used multi-use products at both settings
in the previous year (Supplement Table 2). Additionally,
asthma was associated with occupational use of multi-use
products in spray form (Table 4). Occupational use of
soaps or detergents showed a statistically significant in-
verse association with asthma. In general, ORs appeared
higher when evaluating domestic exposure compared to
occupational exposure.
Regarding the association between biomarkers and the
use of cleaning products both at home and at work, the
initial analysis strategy was stratifying for cases and con-
trols showing highly imprecise results. Therefore, we con-
ducted a cross-sectional analysis including both cases and
controls adjusted for age, sex and smoking status. Occu-
pational use of multi-use products during the previous year,
adjusted for domestic use of the same product, was asso-
ciated with increased levels of FeNO, serum IgE and FGF in
EBC among cases and controls regardless of their symp-
tomatic status (Table 5). Cleaning workers who used glass
cleaners and polishes or waxes at work showed higher levels
of FeNO. Occupational use of glass cleaners was also asso-
ciated with higher levels of TNF-a. The use of hydrochloric
acid and degreasers at work during the previous year was
associated with increased IgE levels. Regarding exposures
at home, domestic use of ammonia during the previous year
was associated with higher levels of 8-isoprostane in EBC
and the use of hydrochloric acid with higher levels of TNF-
a. Geometric means of biomarkers concentrations in EBC
are provided in the online supplement (Supplement Tables
3 and 4).
Table 2 Functional characteristics of cases and controls.
Controls (n Z 44) Cases (n Z 28) Adj. Coeff. (95%CI) b
Prebronchodilator
FEV1/FVC (%) 81.5 (4.4) 76.7 (6.5) 4.4 (7.4 to 1.5)
FVC (% Predicted), mean (SD) 96.7 (12.9) 97.8 (12.7) 3.2 (3.7e10.1)
FEV1 (% Predicted), mean (SD) 99.3 (13.1) 92.8 (11.2) 6.8 (14.0 to 0.3)
FVC (% Predicted) < 85, n (%) 10 (21) 7 (22) 0.5 (0.1e2.2)
FEV1 (% Predicted) < 85, n (%) 5 (11) 9 (28) 1.5 (0.3e6.5)
FEF25e75% (L/s) 2.9 (0.9) 2.4 (0.9) 0.5 (1.0 to 0.1)
Postbronchodilatorc
FEV1/FVC (%) 83.4 (4.9) 77.9 (7.1) 5.2 (8.8 to 1.6)
FVC (% Predicted), mean (SD) 95.5 (12.7) 97.3 (13.2) 1.2 (9.6 to 7.2)
FEV1 (% Predicted), mean (SD) 100.2 (12.4) 93.7 (10.7) 7.8 (14.9 to 0.7)
FVC (% Predicted) < 85, n (%) 11 (23) 9 (28) 1.4 (0.4e4.5)
FEV1 (% Predicted) < 85, n (%) 4 (8) 8 (25) 2.0 (0.4e9.3)
FEF25e75% (L/s) 2.9 (1.2) 2.2 (1.5) 1.0 (2.3 to 0.3)
FEV1/FVC < 0.7, n (%) 0 (0) 3 (11) e
FVC postBD - FVC preBD (mL), mean (SD) 25.2 (17.6) 5.6 (20.5) 9.8 (127e146)
FEV1 postBD - FEV1 preBD (mL), mean (SD) 36.2 (12.6) 62.8 (14.7) 1.5 (83e86)
FVC postBD/FVC preBD (%), mean (SD) 99.1 (5.2) 100.4 (6.0) 1.1 (3.0e5.1)
FEV1 postBD/FEV1 preBD (%), mean (SD) 101.4 (4.6) 102.7 (5.7) 0.2 (2.9e3.3)
Bronchodilator challenge test cutpoints, n (%)
C: 10% change in FEV1 or FVC 2 (5) 3 (11) 2.7 (0.5e14.1)
D: 150 ml change in FEV1 or FVC 8 (19) 6 (24) 1.2 (0.3e4.2)
Bronchial hyperesponsiveness (PD20 < 1 mg), n (%)a 0 (0) 6 (55) e
Bronchial hyperesponsiveness (PD20 <2 mg), n (%)a 3 (27) 9 (82) 8.2 (0.7e97)
a Metacholine challenge test. N Z 11 controls and 11 cases.
b Coefficient and 95%CI from linear regression models adjusted for age, height, sex, and packs-year smoked.
c Spirometry 15 min after the inhalation of 400 mg of salbutamol: n (controls, cases) Z 44, 26.
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This study suggests that cleaning workers with asthma or
asthma symptoms are characterised by non-reversible air-
way obstruction and non-eosinophilic inflammation. Airway
obstruction is indicated by the results of basal spirometry
and bronchodilator challenge testing; non-eosinophilic
inflammation is indicated by the results of FeNO testing.
We found no differences between cases and controls in
levels of biomarkers of oxidative stress or remodelling of the
airways. Asthmatic cleaners are more often atopic and show
higher serum total IgE levels than asymptomatic cleaners.
This is the first study that evaluated thoroughly the
biological characteristics of asthma in cleaning workers.
The lower values of post-bronchodilator FEV1, FEF25e75%
and the ratio FEV1/FVC of cases compared to controls
suggest a functional phenotype with airflow limitation. The
reversibility of bronchial obstruction was not different be-
tween cases and controls. It has been previously reported
that non-eosinophilic asthmatics with low FEV1, are less
commonly bronchodilator test positive compared to eosi-
nophilic asthmatics.27 Thickening of the reticular basal
membrane, considered a histopathologic feature of occu-
pational asthma, may be an alternative explanation for the
non-reversibility of airways obstruction.28 However, the
non-reversibility obstruction of the airways may be due to
the presence of other related diseases such as chronic
obstructive pulmonary disease (COPD) among symptomatic
cases. We evaluated the proportion of cases and controlswith FEV1/FVC lower than 0.70, a diagnostic criterion for
COPD accepted by the international respiratory societies,29
and found that only three out of 42 cases met this criteria.
Therefore, although it cannot be excluded that cases have
other diseases than asthma, our results are not incompat-
ible with known asthma phenotypes. Cases also showed
a higher prevalence of unspecific bronchial hyper-
responsiveness, which was measured in a subsample of 11
cases and 11 controls using the metacholine challenge test.
No differences in age, basal lung function, sex and smoking
habit were found between eligible participants and non-
participants of methacholine challenge testing.
Cases and controls showed, on average, very similar
levels of FeNO, even after adjusting for age, sex and smoking
status. Additional adjustment for other known determinants
such as atopy and body mass index yielded very similar re-
sults, suggesting that these factors were not confounding the
relationship between asthma and FeNO in our population.
Limiting the analysis to cases with current asthma, or to in-
dividuals with adult-onset asthma, did not change the re-
sults. This lack of difference in FeNO suggests that
eosinophilic inflammation does not play a predominant role
in asthma in cleaning workers. This result is compatible with
previous studies reporting that the non-eosinophilic asthma
phenotype is characteristic of irritant-induced asthma,
which has been proposed as themainmechanistic hypothesis
for cleaning-related asthma and asthma-like disorders.14,30
The increased levels of IgE observed among cases com-
pared to controls and the increased proportion of Phadiatop
Table 3 Biological characteristics of cases and controls.
Controls
(n Z 51)
Cases
(n Z 41)
GM ratioa
(95%CI)
GM GM
FeNO (ppb) 19.9 17.9 1.1 (0.8e1.3)
Serum total [IgE] (IU/mL) 14.9 39.7 2.9 (1.5e5.6)
Serum [SP-D] (ng/mL) 39.2 31.2 0.8 (0.5e1.1)
Serum [CC16] (ng/mL) 6.8 5.9 0.9 (0.8e1.2)
Exhaled breath condensate (pg/mL)
[8-isoprostane] 1.9 1.7 1.2 (0.7e1.8)
[Cys-leukotrienes] 55.5 52.0 1.6 (0.7e3.9)
Exhaled breath
condensate
Lower limit of
detection (pg/mL)
% Detectable % Detectable OR* (95%CI)
FGF 3.4 35% 41% 0.6 (0.2e1.7)
IL-13 0.6 20% 32% 1.2 (0.4e3.8)
TNF-a 0.7 18% 29% 1.3 (0.4e4.1)
IFN-g 1.8 10% 5% 0.3 (0.0e2.1)
VEGF 4.5 6% 5% 0.8 (0.1e6.6)
IL-4 1.4 4% 5% n.a.
IL-8 1.2 4% 5% n.a.
Ip10 0.5 2% 2% n.a.
IL-5 1.1 2% 5% n.a.
IL-10 0.1 2% 5% n.a.
IL-12 0.6 2% 5% n.a.
IL-2 11.2 0% 2% n.a.
FeNO: Fraction of exhaled nitric oxide. SP-D: Surfactant Protein D. CC16: 16 kDa Clara Cell Protein. EBC: Exhaled Breath Condensate.
FGF: basic Fibroblast Growth Factor. VEGF: Vascular Endothelial Growth Factor. TNF-a: Tumour Necrosis Factor alpha. IFN-g: Interferon
gamma. Ip10: IFN-geinduced protein. IL: Interleukin.
GM: geometric mean. n.a.: not analysed (<5% of detectables).
a Exponential of the coefficient from linear regression models of the log-transformed variable adjusted for age, sex and smoking
status.
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inhalation of irritants, which facilitates an immunological
response to sensitizers.13,14 In addition, a previous study
showed an association between atopic sensitisation and the
exposure to non-allergenic disinfectants.31 Alternatively,
some cleaning products contain sensitizers, which may
explain the increased levels of IgE.15 In a previous study we
found no association between atopy and asthma and/or
chronic bronchitis in domestic cleaning workers, but higher
total serum IgE level.7 It is important to highlight that
phadiatop test is a method that assesses the levels of
specific IgE levels for ten common aeroallergens, and may
have a component of false positives.32 On the other hand,
an international study with a caseecase design found that
asthmatic cleaners had less atopy than asthmatic office
workers.33 In addition to the above mentioned causes for
increased IgE and atopy, it is important to take into account
that a pre-existing immunological asthma may be aggra-
vated after the exposure to irritants at work.34
Up to date there are no reference values for the studied
EBC biomarkers. For this reason, rather than descriptive we
performed a classic case-control analysis to evaluate the
association of these biomarkers and cleaning-related
asthma. Cases and controls showed similar levels of
8-isoprostane in EBC, which according to the literature is in
line with our results of FeNO.35 Cys-leukotrienes, growth
factors and cytokines levels were also similar in cases andcontrols. The replication of the analyses restricted to cases
with either adult-onset asthma or current asthma did not
show any further association. It has been suggested that
irritant-induced asthma is usually less severe in terms of
control of the disease than immunological asthma, and may
be an alternative explanation for the lack of associations
between respiratory biomarkers and asthma among clean-
ing workers in our study.36
We evaluated both occupational and domestic exposure
to cleaning products, and its association with asthma
symptoms and respiratory biomarkers. Occupational and
domestic use of multi-use products appeared as a con-
sistent risk factor. In addition, multi-use products’ use in
spray form, likely facilitates inhalatory exposure,11 was
strongly associated with asthma. Multi-use product is
a generic term that refers to complex formulae for cleaning
products containing chemicals such as benzenesulfonic acid
and aliphatic alcohols. We also found indications that the
use of irritants including ammonia and hypochlorite
bleach,7e9 polishes or waxes,37 glass cleaners, and dust
mop products was associated with asthma.
The cross-sectional association between the use of spe-
cific products and biomarkers were heterogeneous but,
interestingly, occupational use of multi-use products was
associated with increased levels of FeNO, total IgE and FGF.
This is suggestive of an inflammatory profile more related to
immunological asthma.13,14 We assessed the associations of
Table 4 Occupational and domestic use of cleaning products in the previous year and asthma.
Occupational use in the last year Domestic use in the last year
Controls
(n Z 53)
Cases
(n Z 42)
ORa (95%CI) Controls
(n Z 53)
Cases
(n Z 42)
ORb (95%CI)
n (%) n (%) n (%) n (%)
Ammonia 10 (19) 12 (29) 2.7 (0.9e8.2) 14 (26) 13 (31) 1.1 (0.4e3.2)
Bleach 47 (89) 39 (93) 1.1 (0.1e11) 41 (77) 37 (90) 4.0 (0.8e21)
Degreasers 26 (49) 25 (59) 1.2 (0.5e3.0) 33 (62) 31 (76) 1.5 (0.5e4.6)
Drain products 3 (6) 1 (2) 0.2 (0.0e2.9) 5 (9) 6 (15) 1.3 (0.3e6.0)
Dust mop products 18 (34) 19 (45) 1.9 (0.7e5.2) 8 (15) 8 (20) 0.8 (0.2e3.1)
Glass cleaners 19 (36) 17 (40) 1.0 (0.3e2.7) 28 (53) 31 (76) 3.3 (1.1e9.9)
Hydrochloric acid 4 (8) 5 (12) 1.5 (0.3e7.7) 6 (11) 4 (10) 0.6 (0.1e3.0)
Limescale removers 23 (43) 20 (48) 0.2 (0.1e0.7) 17 (32) 25 (61) 3.8 (0.8e19)
Multi-use products 12 (23) 15 (33) 2.3 (0.7e7.0) 21 (40) 27 (66) 2.1 (0.8e5.8)
Polishes and waxes 7 (13) 6 (14) 1.1 (0.2e5.2) 3 (6) 7 (17) 3.9 (0.8e19)
Soaps or detergents 37 (70) 21 (50) 0.2 (0.1e0.7) 34 (64) 28 (68) 1.5 (0.5e4.5)
Stain removers 5 (9) 4 (9) 0.8 (0.1e4.1) 5 (9) 11 (27) 2.7 (0.7e9.8)
Spray or aerosol form
Multi-use products 5 (9) 7 (17) 4.1 (1.0e18) n.a. n.a. n.a.
Degreasers 8 (15) 9 (21) 1.1 (0.4e3.1) n.a. n.a. n.a.
Dust mop products 16 (30) 17 (40) 1.5 (0.6e3.9) n.a. n.a. n.a.
Limescale removers 4 (8) 4 (10) 1.5 (0.5e5.0) n.a. n.a. n.a.
Glass cleaners 16 (31) 14 (33) 1.2 (0.3e5.9) n.a. n.a. n.a.
Num different sprays
0 22 (42) 14 (33) 1 n.a. n.a. n.a.
1e2 22 (42) 17 (40) 0.8 (0.3e2.4) n.a. n.a. n.a.
3e5 9 (17) 11 (26) 2.1 (0.6e7.4) n.a. n.a. n.a.
n.a.: information not available.
a Odd ratios for asthma and occupational use of cleaning products from logistic regression models adjusted for age, domestic use of the
product, sex and smoking habit. Reference category for each model: no occupational use of the product ever in the last year. One
different model for each product.
b Association between asthma and domestic use of cleaning products using logistic regression models adjusted for age, occupational
use of the product, sex and smoking habit. Reference category for each model: no domestic use of the product ever in the last year. One
different model for each product.
680 D. Vizcaya et al.biomarkers and products without avoiding any possible
mechanistic pathway, thuswedid not adjust for case-control
status. We initially performed a separate analysis for cases
and controls, although it was limited by statistical power
(Supplement Tables 5 and 6). Nevertheless, the associations
between multi-use products and FeNO, total IgE and FGF
pointed in the same direction for cases and controls, sug-
gesting a sub-clinical effect independent of asthma.
A particular strength of this study was the detailed
assessment of functional and biological characteristics of
asthma. We evaluated biomarkers indicative of a variety of
pathophysiological processes including inflammation, oxi-
dative stress, airways damage and affected permeability.
Additional strengths included a confirmation of the case or
control status in an intermediate step between the initial
questionnaire and the clinic visit. The inclusion and exclu-
sion criteria were largely based on reported respiratory
symptoms, which typically show a considerable variability
over time when repeatedly assessed. This is related to the
intermittent nature of the underlying respiratory condition
(true variation) as well as to measurement error.38 Thus,
potential misclassification of asthma status was reduced by
following the conservative approach in which both cases
and controls met the inclusion criteria for case or controlstatus twice, approximately one year apart. As a result, our
final study population included cases with persistent
asthma and/or asthma symptoms and controls without
temporary respiratory symptoms.
There are a number of potential limitations that need to
be considered. First, the study population was relatively
small. This affected the statistical power for detecting
small differences between cases and controls and limited
the assertiveness of the conclusions. This is due in part to
the cross-sectional-nested and workforce-based nature of
the study, what made difficult approaching participants due
to an already limited population and a very restrictive
Spanish legislation on personal data protection that made
impossible to access any workers’ personal data from the
companies.39 However, our industry-based approach pro-
vided us a less biased study population, with a wide range
of occupational exposures. In our opinion, the large amount
of biological and questionnaire data obtained from a highly
inaccessible population and the reduced misclassification
of asthma compensate the low sample size. Furthermore,
our results are consistent with previous reports on asthma
and cleaning workers.1,5 Second, several cleaning products
have strong odours that may have been overreported by
asthmatic cases and potentially lead to a bias of our results
Table 5 Associations between occupational and domestic use of cleaning products and biomarker levels among all cases and controls.
Continuous variables Categorical variables (detectable vs. non-detectable)
FeNO CC16 SP-D IgE 8-Isoprostane Cys-leukotrienes FGF TNF-a IL-13 IFN-g
GMRa (95%CI) GMRa (95%CI) GMRa (95%CI) GMRa (95%CI) GMRa (95%CI) GMRa (95%CI) ORb (95%CI) ORb (95%CI) ORb (95%CI) ORb (95%CI)
Ammonia
Occupational 0.9 (0.7e1.1) 1.0 (0.8e1.3) 1.0 (0.7e1.5) 1.4 (0.7e3.0) 0.9 (0.5e1.4) 1.2 (0.5e3.1) 0.7 (0.2e2.3) 1.4 (0.4e4.8) 0.7 (0.2e2.6) 0.9 (0.1e6.6)
Domestic 1.1 (0.8e1.4) 0.9 (0.7e1.2) 1.0 (0.7e1.5) 0.6 (0.3e1.2) 1.7 (1.1e2.7) 0.4 (0.2e1.1) 1.4 (0.5e4.0) 1.5 (0.5e5.1) 2.5 (0.8e8.6) 1.6 (0.2e12.5)
Bleach
Occupational 1.2 (0.8e1.9) 1.4 (0.9e2.2) 1.6 (0.7e3.5) 2.2 (0.5e9.3) 0.8 (0.3e1.9) 1.2 (0.2e7.5) n.a. n.a. n.a. n.a.
Domestic 0.9 (0.7e1.3) 0.9 (0.6e1.2) 0.9 (0.5e1.5) 1.0 (0.4e2.6) 0.8 (0.4e1.6) 0.9 (0.3e2.9) n.a. n.a. n.a. n.a.
Degreasers
Occupational 1.1 (0.9e1.4) 0.9 (0.7e1.1) 0.8 (0.6e1.2) 1.8 (1.0e3.3) 0.5 (0.3e0.7) 0.7 (0.3e1.6) 0.8 (0.3e2.1) 0.6 (0.2e1.6) 0.7 (0.2e1.9) 0.2 (0.0e1.7)
Domestic 1.1 (0.9e1.4) 1.0 (0.8e1.2) 1.1 (0.7e1.6) 0.9 (0.4e1.7) 0.7 (0.5e1.1) 0.8 (0.3e2.0) 1.1 (0.4e3.3) 1.7 (0.5e6.4) 1.1 (0.3e3.8) 0.3 (0.0e2.1)
Dust mop products
Occupational 1.0 (0.8e1.2) 0.9 (0.8e1.2) 1.0 (0.7e1.5) 1.8 (0.9e3.4) 0.9 (0.6e1.4) 1.5 (0.6e3.3) 1.1 (0.4e2.9) 1.8 (0.6e5.3) 0.7 (0.2e2.1) 3.2 (0.5e20.7)
Domestic 1.1 (0.8e1.4) 1.0 (0.8e1.4) 0.8 (0.5e1.2) 1.0 (0.4e2.5) 1.5 (0.8e2.6) 0.6 (0.2e1.8) 0.8 (0.2e2.9) 0.6 (0.1e2.9) 0.5 (0.1e2.8) 0.5 (0.0e6.2)
Glass cleaners
Occupational 1.3 (1.1e1.7) 0.9 (0.7e1.1) 1.0 (0.7e1.5) 1.4 (0.7e2.7) 1.1 (0.7e1.7) 1.7 (0.7e4.2) 1.4 (0.5e3.9) 3.1 (1.0e9.8) 1.2 (0.4e3.8) 1.0 (0.2e5.8)
Domestic 0.9 (0.7e1.1) 1.0 (0.8e1.3) 0.9 (0.6e1.2) 1.3 (0.6e2.5) 0.9 (0.6e1.5) 0.6 (0.2e1.4) 1.3 (0.5e3.5) 1.7 (0.5e5.9) 1.4 (0.4e4.3) 0.7 (0.1e4.0)
Hydrochloric acid
Occupational 1.2 (0.9e1.7) 0.9 (0.6e1.2) 1.0 (0.5e1.7) 3.5 (1.2e9.8) 1.0 (0.5e2.1) 1.1 (0.3e4.0) 0.8 (0.2e3.9) 0.4 (0.1e3.1) 0.4 (0.1e2.4) 0.8 (0.1e10.9)
Domestic 0.7 (0.5e1.0) 0.8 (0.6e1.2) 1.1 (0.6e2.0) 0.8 (0.3e2.1) 0.9 (0.4e1.9) 0.5 (0.1e1.6) 2.0 (0.5e8.8) 7.3 (1.4e39.1) 4.0 (0.8e20.3) 2.6 (0.2e33.4)
Limescale removers
Occupational 1.1 (0.9e1.4) 1.0 (0.8e1.3) 0.8 (0.6e1.2) 1.6 (0.8e3.0) 0.7 (0.4e1.1) 1.8 (0.8e4.2) 1.0 (0.4e2.6) 0.3 (0.1e1.1) 0.2 (0.1e0.8) 0.1 (0.0e1.5)
Domestic 1.0 (0.8e1.3) 0.9 (0.7e1.1) 1.2 (0.8e1.7) 1.1 (0.6e2.2) 1.1 (0.7e1.7) 1.1 (0.5e2.6) 1.1 (0.4e2.9) 3.0 (0.9e9.9) 1.8 (0.6e5.9) 2.0 (0.3e14.0)
Multi-use products
Occupational 1.4 (1.1e1.7) 1.0 (0.8e1.2) 0.9 (0.6e1.4) 2.1 (1.0e4.2) 1.3 (0.8e2.1) 1.9 (0.8e4.9) 2.9 (1.0e8.7) 2.5 (0.8e7.7) 1.1 (0.4e3.4) 3.1 (0.5e17.4)
Domestic 1.0 (0.8e1.2) 1.0 (0.8e1.3) 1.0 (0.7e1.5) 1.0 (0.5e2.0) 1.0 (0.6e1.5) 1.0 (0.4e2.2) 1.0 (0.4e2.8) 0.9 (0.3e2.6) 1.0 (0.3e2.9) 2.5 (0.4e17.6)
Polishes and waxes
Occupational 1.6 (1.2e2.1) 1.2 (0.8e1.6) 1.4 (0.8e2.4) 1.5 (0.6e4.3) 1.4 (0.7e2.7) 1.0 (0.3e4.0) 0.7 (0.2e3.2) 1.6 (0.4e7.6) 1.8 (0.4e8.1) 1.0 (0.1e10.8)
Domestic 1.0 (0.7e1.3) 0.8 (0.6e1.2) 1.2 (0.7e2.2) 0.7 (0.2e2.0) 1.5 (0.7e3.1) 1.2 (0.3e4.9) 1.1 (0.2e5.3) 1.3 (0.2e7.2) 2.0 (0.4e10.5) 2.9 (0.2e54.5)
Soaps or detergents
Occupational 0.9 (0.8e1.1) 1.0 (0.8e1.3) 0.8 (0.6e1.2) 0.6 (0.3e1.1) 0.8 (0.5e1.2) 0.7 (0.3e1.7) 1.1 (0.4e2.7) 0.7 (0.2e1.9) 0.6 (0.2e1.6) 0.2 (0.0e1.5)
Domestic 1.2 (0.9e1.4) 1.0 (0.8e1.3) 1.2 (0.8e1.7) 0.9 (0.4e1.7) 1.3 (0.8e2.0) 0.9 (0.4e2.1) 1.3 (0.5e3.7) 0.6 (0.2e1.8) 0.9 (0.3e2.6) 0.2 (0.0e1.2)
n.a.: not analysed. FeNO: Fraction of exhaled NO. SP-D: Serum surfactant Protein D. CC16: Serum 16 kDa Clara Cell Protein. EBC: Exhaled Breath Condensate. FGF: EBC basic Fibroblast
Growth Factor. VEGF: EBC Vascular Endothelial Growth Factor. TNF-a: EBC Tumour Necrosis Factor alpha. IFN-g: EBC Interferon gamma. Ip10: EBC IFN-geinduced protein. IL: EBC
Interleukin. Bold indicates statistically significant association at the 95% confidence level.
a Geometric means ratio and 95% confidence intervals from multivariable linear regression models of the log-transformed variables
including all cases and controls. Independent variables included in the models: domestic use of cleaning product, occupational use of
cleaning product, age, sex and smoking habit.
b Odds ratio and 95% confidence intervals from multivariable logistic regression models including all cases and controls. Independent
variables included in the models: domestic use of cleaning product, occupational use of cleaning product, age, sex and smoking habit.
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682 D. Vizcaya et al.away from the null.40 However, the differences in the risks
for domestic and professional use of some odorous products
(e.g., ammonia) suggest that overreporting was unlikely to
have introduced a major bias. Third, in our study popula-
tion, adult-onset asthma cases may be underrepresented as
compared to the previous study9 (Supplement Table 1).
Underrepresented diagnosed asthma cases may have led
our results to an underestimation of the true differences in
biological and functional markers between cases and con-
trols. Finally, we controlled potential confounding by
adjustment for age, sex and smoking status in all analyses.
Current smoking was strongly related to asthma in our
study, and rather than being a strong risk factor for asthma
this was likely driven by the selection criteria for controls,
excluding those with chronic bronchitis symptoms (chronic
cough and chronic phlegm). These symptoms were not part
of the inclusion or exclusion criteria for cases and, as
a result cases had more chronic bronchitis symptoms than
controls. Therefore, the association between current
smoking and asthma was determined by the cases with
chronic bronchitis symptoms. Indeed, when excluding cases
with chronic bronchitis symptoms, the association between
current smoking and case/control status attenuated. When
the main analyses were repeated without adjustment for
smoking status, or when excluding current and former
smokers, no major differences in the associations could be
found. Thus, in spite of a potential overadjustment for
smoking, this is unlikely to have had a major influence on
our findings.
In conclusion, this work contributes to disentangling the
physiological characteristics of the respiratory disorders
associated to cleaning-related exposures. Our results sug-
gest that a non-reversible bronchial obstruction component
is present in cleaners with asthma and/or asthma symptoms
and that eosinophilic inflammation and oxidative stress are
unlikely to play a key role in the increased risk of asthma
symptoms. Our findings about occupational and domestic
exposure to cleaning products are complementary to those
published previously in this study population9,41 and high-
light the importance both for general public health and
occupational safety. Further studies on the mechanisms of
asthma in individuals exposed to cleaning agents are
recommended.
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